Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3736 AL 3750

Music-based intervention as a new therapeutic treatment for executive dysfunction in Parkinson's disease

Wang Z, Liu Y, Li C, Qin K, Yu X, Xie A.

Neuroscience. 2025 Aug 6;580:306-314. doi: 10.1016/j.neuroscience.2025.06.057. Epub 2025 Jun 28.

Immunization targeting diseased proteins in synucleinopathy and tauopathy: insights from clinical trials

Zhan X, Wen G, Wu X, Li JY.

Transl Neurodegener. 2025 Jul 1;14(1):33. doi: 10.1186/s40035-025-00490-9.

Artificial Intelligence in Cognitive Decline Diagnosis: Evaluating Cutting-Edge Techniques and Modalities

Gharehbaghi A, Babic A.

Stud Health Technol Inform. 2025 Jun 26;328:46-50. doi: 10.3233/SHTI250670.

Gaps in the Parkinson's disease therapeutic clinical pipeline: A focus on approaches targeting disease pathobiology

Koros C, Fiske B, Stefanis L.

J Parkinsons Dis. 2025 Jun 30:1877718X251354935. doi: 10.1177/1877718X251354935. Online ahead of print.

GAN-based Denoising for Scan Time Reduction and Motion Correction of 18 F FP-CIT PET/CT: A Multicenter External Validation Study

Han H, Choo K, Jeon TJ, Lee S, Seo S, Kim D, Kim SJ, Lee SH, Yun M.

Clin Nucl Med. 2025 Oct 1;50(10):e580-e588. doi: 10.1097/RLU.0000000000006040. Epub 2025 Jul 1.

Biallelic ELOVL1 Variants Are Linked to Hypomyelinating Leukodystrophy, Movement Disorder, and Ichthyosis

Wong KM, Maroofian R, Meier K, Diegmann S, Tkemaladze T, Alvi JR, Tasharrofi B, Efthymiou S, Munchau A, Korenke GC, Almontashiri N, Eyaid W, Kashgari A, Alotaibi M, Gärtner J, Huppke B, Asadollahi M, Chikvinidze G, Keramatipour M, Sultan T, Thiele H, Nürnberg P, Gräler MH, Houlden H, Huppke P.

Mov Disord. 2025 Sep;40(9):1836-1850. doi: 10.1002/mds.30258. Epub 2025 Jul 1.

Comparative efficacy and safety of irreversible (rasagiline) and reversible (safinamide) monoamine oxidase inhibitors as add-on therapy for Parkinson's disease

Khalid MB, Shahzad F, Siddiqui MR, Abedin MZU, Hulou S, Shami B, Ahmed SI.

J Neurol. 2025 Jul 1;272(7):486. doi: 10.1007/s00415-025-13230-w.

Non-invasive brain stimulation to enhance sleep quality and architecture in Parkinson's disease: A systematic review and Bayesian network meta-analysis

Cristini J, Medina-Rincon A, Van Roy A, Seo F, Moncion K, Carrier J, Paquette C, Dagher A, Steib S, Roig M.

Sleep Med Rev. 2025 Aug;82:102117. doi: 10.1016/j.smrv.2025.102117. Epub 2025 Jun 19.

A multicenter longitudinal study of cholinergic subgroups in Parkinson disease

Bohnen NI, Roytman S, van der Zee S, Carli G, Michalakis F, Luker A, Slingerland S, Frey KA, Scott PJH, Koeppe RA, van Laar T, Albin RL, Kanel P.

Nat Commun. 2025 Jul 1;16(1):5655. doi: 10.1038/s41467-025-60815-0.

Patient, target, device, and program selection for DBS in Parkinson's disease: advancing toward precision care

Wagle Shukla A, Bange M, Muthuraman M.

NPJ Parkinsons Dis. 2025 Jul 1;11(1):195. doi: 10.1038/s41531-025-01015-x.

Aerobic exercise-induced changes in fluid biomarkers in Parkinson's disease

Luthra NS, Mehta N, Munoz MJ, Fantuzzi G, Lamotte G, Haus JM, McFarland NR, Tansey MG, Gonzalez-Latapi P, Caraveo G, Kang UJ, Corcos DM.

NPJ Parkinsons Dis. 2025 Jul 1;11(1):190. doi: 10.1038/s41531-025-01042-8.

Impact of motor symptom asymmetry on non-motor outcomes in Parkinson's disease: a systematic review

Voruz P, Guérin D, Péron JA.

NPJ Parkinsons Dis. 2025 Jul 1;11(1):188. doi: 10.1038/s41531-025-01046-4.

Machine learning for Parkinson's disease: a comprehensive review of datasets, algorithms, and challenges

Shokrpour S, MoghadamFarid A, Bazzaz Abkenar S, Haghi Kashani M, Akbari M, Sarvizadeh M.

NPJ Parkinsons Dis. 2025 Jul 1;11(1):187. doi: 10.1038/s41531-025-01025-9.

Influence of wearable rhythmic auditory stimulation on Parkinson's disease, multiple sclerosis, and stroke: a systematic review and meta-analysis

Scataglini S, Van Bocxlaer C, Jansen L, Van Es L, Van Laerhoven C, Truijen S.

Sci Rep. 2025 Jul 1;15(1):21432. doi: 10.1038/s41598-025-05952-8.

Alpha-synuclein seeding amplification assays in Lewy body dementia: a brief review

Bregendahl M, Kaya ZB, Singer W, McLean PJ.

Mol Neurodegener. 2025 Jul 1;20(1):77. doi: 10.1186/s13024-025-00868-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias